Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
Status:
Completed
Trial end date:
2016-02-18
Target enrollment:
Participant gender:
Summary
A phase II trial evaluating intra-hepatic chemotherapy with oxaliplatin every second week in
combination with systemic gemcitabine and capecitabine in combination with cetuximab in
patient with non-resectable liver metastases from cholangiocarcinoma.